These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 26518893)

  • 1. The Notch signaling pathway in esophageal adenocarcinoma.
    Wang Z; Chen J; Capobianco AJ
    Cell Mol Biol (Noisy-le-grand); 2015 Oct; 61(6):24-32. PubMed ID: 26518893
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Blocking the NOTCH pathway can inhibit the growth of CD133-positive A549 cells and sensitize to chemotherapy.
    Liu J; Mao Z; Huang J; Xie S; Liu T; Mao Z
    Biochem Biophys Res Commun; 2014 Feb; 444(4):670-5. PubMed ID: 24502949
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dysfunctional transforming growth factor-β signaling with constitutively active Notch signaling in Barrett's esophageal adenocarcinoma.
    Mendelson J; Song S; Li Y; Maru DM; Mishra B; Davila M; Hofstetter WL; Mishra L
    Cancer; 2011 Aug; 117(16):3691-702. PubMed ID: 21305538
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Conversion of metaplastic Barrett's epithelium into post-mitotic goblet cells by gamma-secretase inhibition.
    Menke V; van Es JH; de Lau W; van den Born M; Kuipers EJ; Siersema PD; de Bruin RW; Kusters JG; Clevers H
    Dis Model Mech; 2010; 3(1-2):104-10. PubMed ID: 20075383
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Notch signaling drives stemness and tumorigenicity of esophageal adenocarcinoma.
    Wang Z; Da Silva TG; Jin K; Han X; Ranganathan P; Zhu X; Sanchez-Mejias A; Bai F; Li B; Fei DL; Weaver K; Carpio RV; Moscowitz AE; Koshenkov VP; Sanchez L; Sparling L; Pei XH; Franceschi D; Ribeiro A; Robbins DJ; Livingstone AS; Capobianco AJ
    Cancer Res; 2014 Nov; 74(21):6364-74. PubMed ID: 25164006
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Downregulation of Notch pathway by a gamma-secretase inhibitor attenuates AKT/mammalian target of rapamycin signaling and glucose uptake in an ERBB2 transgenic breast cancer model.
    Efferson CL; Winkelmann CT; Ware C; Sullivan T; Giampaoli S; Tammam J; Patel S; Mesiti G; Reilly JF; Gibson RE; Buser C; Yeatman T; Coppola D; Winter C; Clark EA; Draetta GF; Strack PR; Majumder PK
    Cancer Res; 2010 Mar; 70(6):2476-84. PubMed ID: 20197467
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Curcumin induces cell death in esophageal cancer cells through modulating Notch signaling.
    Subramaniam D; Ponnurangam S; Ramamoorthy P; Standing D; Battafarano RJ; Anant S; Sharma P
    PLoS One; 2012; 7(2):e30590. PubMed ID: 22363450
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dysfunctional transforming growth factor-β signaling with constitutively active notch signaling in Barrett's esophageal adenocarcinoma.
    Masuda S
    Cancer; 2012 Apr; 118(7):1956-7; author reply 1957-8. PubMed ID: 21898377
    [No Abstract]   [Full Text] [Related]  

  • 9. Notch signaling drives development of Barrett's metaplasia from Dclk1-positive epithelial tuft cells in the murine gastric mucosa.
    Kunze B; Middelhoff M; Maurer HC; Agibalova T; Anand A; Bührer AM; Fang HY; Baumeister T; Steiger K; Strangmann J; Schmid RM; Wang TC; Quante M
    Sci Rep; 2021 Feb; 11(1):4509. PubMed ID: 33627749
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Notch signaling is inactive but inducible in human embryonic stem cells.
    Noggle SA; Weiler D; Condie BG
    Stem Cells; 2006 Jul; 24(7):1646-53. PubMed ID: 16614005
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Notch signaling, gamma-secretase inhibitors, and cancer therapy.
    Shih IeM; Wang TL
    Cancer Res; 2007 Mar; 67(5):1879-82. PubMed ID: 17332312
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alterations of the Wnt signaling pathway during the neoplastic progression of Barrett's esophagus.
    Clément G; Braunschweig R; Pasquier N; Bosman FT; Benhattar J
    Oncogene; 2006 May; 25(21):3084-92. PubMed ID: 16407829
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Small molecules that inhibit Notch signaling.
    De Kloe GE; De Strooper B
    Methods Mol Biol; 2014; 1187():311-22. PubMed ID: 25053499
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transient gamma-secretase inhibition accelerates and enhances fracture repair likely via Notch signaling modulation.
    Wang C; Shen J; Yukata K; Inzana JA; O'Keefe RJ; Awad HA; Hilton MJ
    Bone; 2015 Apr; 73():77-89. PubMed ID: 25527421
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suppression of the notch signaling pathway by γ-secretase inhibitor GSI inhibits human nasopharyngeal carcinoma cell proliferation.
    Chen SM; Liu JP; Zhou JX; Chen C; Deng YQ; Wang Y; Tao ZZ
    Cancer Lett; 2011 Jul; 306(1):76-84. PubMed ID: 21420785
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Conjugated Bile Acids Promote Invasive Growth of Esophageal Adenocarcinoma Cells and Cancer Stem Cell Expansion via Sphingosine 1-Phosphate Receptor 2-Mediated Yes-Associated Protein Activation.
    Liu R; Li X; Hylemon PB; Zhou H
    Am J Pathol; 2018 Sep; 188(9):2042-2058. PubMed ID: 29963993
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Notch signaling in breast cancer and tumor angiogenesis: cross-talk and therapeutic potentials.
    Shi W; Harris AL
    J Mammary Gland Biol Neoplasia; 2006 Jan; 11(1):41-52. PubMed ID: 16947085
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanisms and clinical prospects of Notch inhibitors in the therapy of hematological malignancies.
    Nefedova Y; Gabrilovich D
    Drug Resist Updat; 2008 Dec; 11(6):210-8. PubMed ID: 18951834
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of NOTCH signaling via DLL1 is mediated by APE1-redox-dependent NF-κB activation in oesophageal adenocarcinoma.
    Chen L; Lu H; Peng D; Cao LL; Ballout F; Srirmajayam K; Chen Z; Bhat A; Wang TC; Capobianco A; Que J; McDonald OG; Zaika A; Zhang S; El-Rifai W
    Gut; 2023 Mar; 72(3):421-432. PubMed ID: 35750470
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New insights into Notch1 regulation of the PI3K-AKT-mTOR1 signaling axis: targeted therapy of γ-secretase inhibitor resistant T-cell acute lymphoblastic leukemia.
    Hales EC; Taub JW; Matherly LH
    Cell Signal; 2014 Jan; 26(1):149-61. PubMed ID: 24140475
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.